Lauren Merendino is CCO at Myovant Sciences Ltd. (MYOV). They have made 8 open-market trades across 2 companies since 2022, most recently 2026-02-17.
CIK 0001855298
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MYOV | 147,747 | $4.0M |
| DAWN | 60,157 | $1.3M |
| Total | $5.3M |
Shares reported on the most recent Form 4, priced at the 2026-02-18 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DAWN | SELL | 2026-02-17 | 2026-02-18 | $11.60 | $67K | -9.8% | +86.3% | N/A |
| DAWN | SELL | 2025-11-17 | 2025-11-18 | $8.91 | $33K | +3.0% | +17.0% | +39.4% |
| DAWN | SELL | 2025-08-18 | 2025-08-19 | $6.77 | $25K | +10.9% | +6.5% | +30.6% |
| DAWN | SELL | 2025-05-16 | 2025-05-19 | $6.26 | $25K | -0.6% | -0.2% | +6.1% |
| MYOV | SELL | 2023-01-18 | 2023-01-20 | $26.89 | $108K | +0.0% | +0.1% | N/A |
| MYOV | SELL | 2022-10-18 | 2022-10-20 | $25.20 | $43K | +10.3% | +10.3% | +10.7% |
| MYOV | SELL | 2022-07-18 | 2022-07-20 | $12.87 | $22K | +8.2% | +43.2% | +99.8% |
| MYOV | SELL | 2022-04-19 | 2022-04-21 | $10.45 | $147K | +7.3% | +9.3% | +29.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.